For Health Professionals

FDA Expert Commentary and Interview Series on Medscape

As part of the continuing collaboration between FDA and Medscape disclaimer icon, a series of interviews and commentaries are available to communicate important safety information to clinicians. Featuring FDA experts, these original commentaries cover a wide range of topics related to FDA's multi-faceted mission of protecting and promoting the public health by ensuring the safety and quality of medical products such as drugs, foods, and medical devices.

The complete terms and framework of the partnership with Medscape are described in the Memorandum of Understanding.

Interviews

 

group of children

Montelukast's Underrecognized Adverse Drug Events

http://www.medscape.com/viewarticle/840302 disclaimer icon

Featuring Sally Seymour, MD, and Erika Torjusen, MD, MHS, FDA Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology, March 2015

 


 

 pregnant woman

FDA Updates Labels for Pregnant and Breastfeeding Women

http://www.medscape.com/viewarticle/837337 disclaimer icon

Featuring Melissa S. Tassinari, PhD, and Jeanine Best, MSN, RN, PNP, FDA Center for Drug Evaluation and Research, Division of Pediatric and Maternal Health, January 2015

 


 

 Gayatri R. Rao, MD, JD, Director, Office of Orphan Products Development, FDA

Targeting Drugs for Rare Diseases

http://www.medscape.com/viewarticle/834442 disclaimer icon

Featuring Gayatri R. Rao, MD, JD, Director, FDA Office of Orphan Products Development, November 2014

 


 

 Margaret A. Hamburg, MD           

Balancing the Risks, Benefits for 310 Million Patients

http://www.medscape.com/viewarticle/834134 disclaimer icon

Featuring Margaret A. Hamburg, MD, Commissioner, U.S. Food and Drug Administration, November 2014

 


 

Responding to Ebola: The View From the FDA

http://www.medscape.com/viewarticle/830142 disclaimer icon

Featuring Luciana Borio, MD, FDA Acting Deputy Chief Scientist and Assistant Commissioner for Counterterrorism Policy in the Office of Counterterrorism and Emerging Threats, August 2014

 


 

FDA Approval 2.0: Dr. Kandzari Interviews Dr. Bill Maisel

http://www.medscape.com/viewarticle/824087 disclaimer icon

A discussion with Dr. Bill Maisel, Deputy Center Director for Science, FDA Center for Devices and Radiological Health, on strategies to expedite FDA approval while maintaining scientific rigor. April 2014

 


 

The New Food Labels: Information Clinicians Can Use

http://www.medscape.com/viewarticle/822925 disclaimer icon

Featuring Jessica Leighton, PhD, MPH, Senior Advisor for Nutrition Science and Policy, and Claudine Kavanaugh, PhD, MPH, RD, Health Scientist, FDA Office of Foods and Veterinary Medicine, April 2014

 


 

 Dr. Anne Pariser     

FDA's Rare Disease Program: A Rare Opportunity to Help Kids

http://www.medscape.com/viewarticle/821918 disclaimer icon

Featuring Anne Pariser, MD, Associate Director for Rare Diseases, Office of New Drugs, and Andrew Mulberg, MD, Deputy Director, Division of Gastroenterology and Inborn Error Products, FDA Center for Drug Evaluation and Research, March 2014

 


 

 Capt. Valerie Jensen, RPh   

Critical Intravenous Solution Shortages

http://www.medscape.com/viewarticle/8203985 disclaimer icon

Featuring Capt. Valerie Jensen, RPh, Associate Director, Drug Shortages Program, FDA Center for Drug Evaluation and Research, February 2014

 


 

 Mitch Zeller, JD, Director, FDA Center for Tobacco Products   

Preventing Teen Tobacco Use

http://www.medscape.com/viewarticle/820327 disclaimer icon

Featuring Mitch Zeller, JD, Director, FDA Center for Tobacco Products, February 2014

 


 

Acetaminophen, Opioids, and Safety

http://www.medscape.com/viewarticle/820039 disclaimer icon

Featuring Sharon Hertz, MD, Deputy Director, Division of Anesthesia, Analgesia, and Addiction Products, Center for Drug Evaluation and Research, February 2014

 


 

 photo of latex gloves  

Redefining 'Latex-Free'

http://www.medscape.com/viewarticle/819226 disclaimer icon

Featuring Geetha C. Jayan, MVSc, PhD, PMP, and Michael T. Bailey, PhD, FDA Center for Devices and Radiological Health, January 2014

 


 

Removing Trans Fats From Foods: The FDA's View

http://www.medscape.com/viewarticle/814778 disclaimer icon

Featuring Dennis Keefe, PhD, Director, FDA Office of Food Additive Safety, November 2013

 


 

Breast Implants: The View From the FDA

http://www.medscape.com/viewarticle/807689 disclaimer icon

Featuring Binita Ashar, MD, MBA, FACS, and David Krause, PhD, FDA Office of Device Evaluation, July 2013

 


 

Flu and the FDA

http://www.medscape.com/viewarticle/777966 disclaimer icon

Featuring Margaret A. Hamburg, MD, Commissioner, U.S. Food and Drug Administration, January 2013

 


 

 Why Contact Lens Adverse Events Matter

Telling the FDA: Why Contact Lens Adverse Events Matter

http://www.medscape.com/viewarticle/774062

Featuring Bernard P. Lepri, OD, MS, MEd, and Michelle Tarver, MD, PhD, FDA Office of Device Evaluation, November 2012

 


 

Decorative Contact Lenses: Truly Frightening 
http://www.medscape.com/viewarticle/773106

Featuring Michelle Tarver, MD, PhD, FDA Office of Device Evaluation, October 2012

 


 

Contact Lenses: The Risks You Need to Know 
http://www.medscape.com/viewarticle/773026

Featuring Bernard P. Lepri, OD, MS, MEd, FDA Office of Device Evaluation, October 2012

 


 

Quinine and Leg Cramps: Not Worth the Risk 
http://www.medscape.com/viewarticle/771699 disclaimer icon

Featuring Hala H. Shamsuddin, MD, Medical Officer, Office Of Antimicrobial Products, FDA Center for Drug Evaluation and Research, October 2012

 


 

 

The New Opioid REMS: The FDA View  
http://www.medscape.com/viewarticle/770644 disclaimer icon

Featuring Gerald J. Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, FDA Center for Drug Evaluation and Research, September 2012

 


 

 Elliot Cowan, PhD, Chief, Product Review Branch,  Division of Emerging and Transfusion Transmitted Diseases 

At-Home Rapid HIV Testing: An Interview With FDA
http://www.medscape.com/viewarticle/768250
 disclaimer icon

Featuring Elliot Cowan, PhD, Chief, Product Review Branch, Division of Emerging and Transfusion Transmitted Diseases, FDA Center for Biologics Evaluation and Research, July 2012

 


 

FDA Expert Interview 

Statins: The Story Behind the Label Changes disclaimer icon 
http://www.medscape.com/viewarticle/759736

Featuring Amy Egan, MD, MPH, Deputy Director for Safety, Division of Metabolism and Endocrinology Products, March 2012

 


 

FDA Expert Interview

Simvastatin 80 mg: An FDA Expert Interview disclaimer icon
http://www.medscape.com/viewarticle/747280

Featuring Amy Egan, MD, MPH, Deputy Director for Safety, Division of Metabolism and Endocrinology Products, August 2011

 


 

Ticagrelor: The View From the FDA

Ticagrelor: The View From the FDA disclaimer icon
http://www.medscape.com/viewarticle/747175

Featuring Norman Stockbridge, MD, PhD, Director, Division of Cardiovascular and Renal Products, July 2011

 


 

The Changes in Sunscreen Labeling

The Changes in Sunscreen Labeling disclaimer icon
http://www.medscape.com/viewarticle/745500

Featuring Reynold Tan, PhD, Interdisciplinary Scientist, Division of Nonprescription Regulation Development, July 2011

 


 

 

 

Video Programs 

 

FDA Drug Safety Communications:
What You Need to Know When You Need to Know It 
disclaimer icon

http://www.medscape.com/viewarticle/767477 

Featuring Dr. Gregory Busse, Team Lead for Drug Safety Communication in the FDA Center for Drug Evaluation and Research, July 2012

 


 

 
Dr. Gerald Dal Pan, Acting Director, FDA Office of Surveillance and Epidemiology in the Center for Drug Evaluation and Research  
 

A Short Tutorial on REMS: The FDA Perspective disclaimer icon 
http://www.medscape.com/viewarticle/762240

Featuring Dr. Gerald Dal Pan, Acting Director, FDA Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, April 2012

 


 

 
Dr. Diane Mitchell, Assistant Director for Science in the FDA Center for Devices and Radiological Health
 

Repairing Pelvic Organ Prolapse: What's Best? disclaimer icon  
http://www.medscape.com/viewarticle/761692

Featuring Dr. Diane Mitchell, Assistant Director for Science for FDAs Center for Devices and Radiological Health, April 2012

 


 

What To Do About Misleading Drug Ads disclaimer icon 
http://www.medscape.com/viewarticle/754890

Featuring Michael Sauers, Team Leader for FDAs Office of Prescription Drug Promotion in the Center for Drug Evaluation and Research, December 2011

 


 

 

The Problem with Drug Shortages

The Problem With Drug Shortages disclaimer icon
http://www.medscape.com/viewarticle/752440

Featuring Jouhayna Saliba, PharmD, Senior Regulatory Program Manager for FDA's Drug Shortage Program in the Center for Drug Evaluation and Research, November 2011

 


 

 

Current and Future State of Drug-Eluting Stents thumbnail

Current and Future State of Drug-Eluting Stents disclaimer icon
http://www.medscape.com/viewarticle/751715

Featuring Ashley Boam, BSE, MSBE, Chief of FDA's Interventional Cardiology Devices Branch, and Andrew Farb, MD, Medical Officer and Senior Reviewer in the Interventional Cardiology Devices Branch, October 2011

 


 

 
Surgical Fires: How They Start and How to Prevent Them

Surgical Fires: How They Start and How to Prevent Them disclaimer icon
http://www.medscape.com/viewarticle/751171

Featuring Stephanie Joseph, FDA Biomedical Engineer, Center for Devices and Radiological Health and Dr. Kenneth Silverstein, Chair, Department of Anesthesiology and Medical Director, Perioperative Services at Christiana Care Health System, October 2011

 


 

•	FDA Commissioner: "Safety Science" Key to Drug Regulation

FDA Commissioner: "Safety Science" Key to Drug Regulation disclaimer icon
http://www.medscape.com/viewarticle/736393

Featuring Dr. Margaret Hamburg, Commissioner of the FDA, February 2011

 


 

Food Recalls: FDA Takes Preventive Approach

Food Recalls: FDA Takes Preventive Approach disclaimer icon
http://www.medscape.com/viewarticle/736909

Featuring Michael Taylor, FDA Deputy Commissioner for Foods, February 2011

 


 

Safe Use of Drugs Requires Reports From Clinicians

Safe Use of Drugs Requires Reports From Clinicians disclaimer icon
http://www.medscape.com/viewarticle/737204

Karen Weiss, MD, MPH, Program Director for the FDA's Safe Use Initiative, February 2011

 


 

Are You Prescribing Unapproved Drugs?

Are You Prescribing Unapproved Drugs? disclaimer icon
http://www.medscape.com/viewarticle/737615

Charles E. Lee, MD, Medical Officer in the Office of Compliance, March 2011

 


 

 
 

 

Continuing Education Programs

 

Page Last Updated: 04/27/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.